Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular dated 13thJuly, 2023, Indraprastha Medical Corporation has informed that the Company has received a letter from the Govt. of NCT of Delhi (‘Promoter of the Company’) intimating about withdrawal of nomination of Jasmine Shah from the Board of Directors of the Company, and accordingly, Jasmine Shah has ceased to be the Non-Executive Director & Chairman of the Company. The detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBIVHO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure-A. Further, a copy of aforesaid letter for withdrawal of nomination is also enclosed as Annexure- B.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7270.35 |
Max Healthcare Inst | 1140.55 |
Narayana Hrudayalay | 1307.35 |
Aster DM Healthcare | 503.45 |
Global Health | 1098.05 |
View more.. |